Nature Cancer is a journal dedicated to publishing the latest advances across all areas of cancer research.
Joined January 2019
- Tweets 2,022
- Following 370
- Followers 39,502
- Likes 1,976
539 Photos and videos
Pinned Tweet
🍓☀️Check out our May Issue, now live!
Including:
☑️Oncolytic virus and cytokine-based gene therapies
☑️Myeloid plasticity, part of our Series on Tumor Heterogeneity and Plasticity
☑️DeepFAN, a model for human-AI collaboration
and more!
nature.com/natcancer/volumes…
4
6
1,223
Jun 11
⭐️Online now
Iron level and ferroptosis impair antitumor efficacy of CAR-T cells.
by Dongrui Wang, Yongxian Hu, Pengxu Qian, He Huang & colleagues
nature.com/articles/s43018-0…
16
40
2,751
Jun 11
📢Online now!
@MoritzGerstung, Felix Sahm & co developed an AI algorithm that leverages H&E slides to classify central nervous system tumors into methylation-based subtypes reducing turnaround time to 12 min in prospective evaluation.
nature.com/articles/s43018-0…
6
27
2,373
⭐️Now online
In a large cohort of patients with ICB-treated glioblastoma, Catherine J. Wu & colleagues show that baseline mesenchymal transcriptional state predicts therapy response, and transition to non-mesenchymal state results in acquired resistance.
nature.com/articles/s43018-0…
1
15
35
3,639
Nature Cancer retweeted
🔥Bacterial engineering for cancer therapy
🆙 @NatureCancer
☑Engineered bacteria as living drug delivery systems for cytotoxics & immunotherapeutics
🎯Payload selection, controlled release & safety optimization are key for clinical translation
🎙Dr. Noah Chen @arpaialab
@OncoAlert @Larvol
nature.com/articles/s43018-0…
8
11
2,425
Nature Cancer retweeted
Calling all scientists working on bedside omics, biomarkers, therapeutics, & precision health-related topics. Share your latest findings w/ global experts @NatureMedicine @NatureCancer & @CommsMedicine editors at our inaugural Flagship.
Submit by 6/30> go.nature.com/4uTnDww
6
3
1,108
Nature Cancer retweeted
Jun 3
Delighted to share our @NatureCancer paper, out today, on determinants of ICB response in GBM (link in 🧵)
With bulk and single-nucleus genomic profiling of 181 ICB-treated tumors, we found that tumor RNA subtype (and not TMB!) predicts survival and shapes acquired resistance.
1
6
9
2,363
Nature Cancer retweeted
Excited to share some of my PhD work out today in @NatureCancer! Integrating bulk and single-nucleus genomic approaches, we identify distinct determinants of survival and acquired resistance to ICB versus standard chemoradiation in glioblastoma. nature.com/articles/s43018-0…
5
24
98
13,420
May 28
🚨New in Nature Cancer
Kimberly J. Perez and colleague show that adding the VDR agonist paricalcitol to gemcitabine nab‑paclitaxel in metastatic pancreatic cancer is feasible and and provides early indications of TME remodeling @DanaFarber @Cancer
nature.com/articles/s43018-0…
1
3
992
May 15
Out today!
CD300ld, upregulated in pathologically activated neutrophils, mediates contact-dependent suppression of cytotoxic CD8 T cells by binding to phosphatidylserine, inhibiting antitumor immune responses and revealing a targetable checkpoint pathway
nature.com/articles/s43018-0…
2
12
21
2,581
May 15
🌟Online now!
The Review on myeloid cell plasticity in cancer therapy by Dmitry Gabrilovich & colleagues @GabrilovichLab
🔗nature.com/articles/s43018-0…
Check out the rest of the Series on Tumor Heterogeneity and Plasticity here:
nature.com/collections/gfbbj…
12
37
3,265
May 12
⭐Out today!
Read the phase I clinical trial on neoantigen DNA vaccine for patients with glioblastoma
nature.com/articles/s43018-0…
1
4
18
1,555
May 11
⭐️Check out the Perspective on cellular neighborhoods in cancer by @LichunMa, @KaiTanLab1 & co
🔗nature.com/articles/s43018-0…
Part of our Series on Tumor Heterogeneity and Plasticity:
nature.com/collections/gfbbj…
2
17
65
4,403
A phase 1 clinical trial now published @naturecancer
'Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors'
✒️By Hilde De Winter & colleagues
🔗nature.com/articles/s43018-0…
1
3
17
3,521
⭐️Don't miss this Review published @NatureCancer
as part of our Series on Tumor Heterogeneity and Plasticity
'Heterogeneity and plasticity of cancer-associated fibroblasts'
✒️By Ruth Scherz-Shouval, Mara Sherman and co-authors
🔗nature.com/articles/s43018-0…
2
40
118
8,036
🔥Online now, a Review on EMT as driver of tumor cell plasticity
By @NietoAngela and @ruljc
Part of our Series on Tumor Heterogeneity and Plasticity: nature.com/collections/gfbbj…
nature.com/articles/s43018-0…
1
11
21
1,974
Our Senior Editor Julieta Alfonso is excited to join the Europe's Cancer Immunotherapy CIMT Annual Meeting on May 11-13 2026 in Mainz. Please reach out to her if you are around! meeting.cimt.eu/
2
4
1,084
🌷Our April Issue is out!
Featuring:
☑️Our Series on Tumor Heterogeneity and Plasticity
☑️CAR T cell therapy in solid tumors
☑️An erythrocyte–anti-PD1 conjugate
☑️Pediatric tumors classification using cfDNA methylation
and more!
nature.com/natcancer/volumes…
1
8
32
2,531
Apr 29
📢Today we launch our Series on Tumor Heterogeneity and Plasticity featuring commissioned Reviews and a selection of articles published in Nature Cancer!
Read about EMT, CAF plasticity, immune cell plasticity, cellular neighborhoods and more here:
🔗nature.com/collections/gfbbj…
1
57
186
10,511
Nature Cancer retweeted
Reframing Precision Medicine tackles a defining challenge: how do we implement precision medicine at scale?
Attend to:
- Gain real-world insight.
- Explore AI & multi-omics.
- Connect across the ecosystem.
Early bird ends 30 April → save up to £400: go.nature.com/4tx2ZBP
1
5
1
1,281